Showing results (311-320 of 1,371) with videos related to
Sort By:
Pageof 138
Drug Development Research|July 9, 2026
The Expanding Role of Indole Scaffolds in Combating Antimicrobial ResistanceVidyasagar, Jagritee Yadav, Meenakshi SinghDrug Development Research|July 13, 2026
Discovery of Novel PCSK9-LDLR PPI Inhibitors by a Structural Modification ApproachHuan Zhu, Zhiqin Zhang, Lihui Zhang, et al.Drug Development Research|July 20, 2026
Two Novel 1,4-Naphthoquinone Derivatives as Potent Agents Against Multidrug-Resistant Staphylococcus aureus and Pathogenic Gram-Positive BacteriaHyunChan Song, Haena Lee, Ji-Hyun Yoon, et al.Drug Development Research|August 3, 2026
GRP78 Drives NSCLC Stemness and EMT via a SIX1/β-Catenin Signaling AxisGuoping Tong, Huanyu QiDrug Development Research|August 10, 2026
Alternative Splicing in Cyclin-Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast CancerYuqiu Cui, Jia Xie, Jiale Cai, et al.Drug Development Research|August 25, 2026
Sulfonamide-Based 2-Amino-1,3,4-Oxadiazole Derivatives as Dual Cholinesterase and Carbonic Anhydrase Inhibitors: Design, Synthesis, Kinetic Characterization, Molecular Modeling, and ADMET EvaluationGülnur Arslan Karahan, Başak Gökçe, Muhammed Tilahun Muhammed, et al.Drug Development Research|December 8, 2022
Urolithin A suppresses tumor progression and induces autophagy in gastric cancer via the PI3K/Akt/mTOR pathwayYingjing Zhang, Lin Jiang, Pengfei Su, et al.Drug Development Research|October 14, 2020
Sigma-1 receptor antagonist (BD-1063) potentiates the antinociceptive effect of quercetin in neuropathic pain induced by chronic constriction injuryJosué Vidal Espinosa-Juárez, Osmar Antonio Jaramillo-Morales, Myrna Déciga-Campos, et al.Drug Development Research|October 28, 2020
Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathwayJunjiang Liu, Yunxia Zhang, Chunhong Yu, et al.Pageof 138